☆ 4.7 Letter

Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)

LEUKEMIA (2022)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 36, Issue 5, Pages 1436-1439

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-022-01537-w

Keywords

-

Categories

Oncology Hematology

Funding

  1. Celgene
  2. Swedish Cancer Society
  3. Nordic Cancer Union

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.